surpass trial tirzepatide is finally here – what's the big deal? – GP Voice Latest Data From SURPASS Trials

Ozempic, metformin ER, Invokana, Tradjenta, and Mounjaro are some Victoza alternatives

we specialize in BHRT and our sterile implantable pellets are considered the best in the industry, and are shipped out of our 503B FDA Registered Outsourcing Facility

If you want to contact us please email [email protected]

Harrison et al

Purpose of Review This review will summarize the most contemporary trials for glucagon-like peptide 1 receptor agonists (GLP1-RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2-i) and present guidance on management and recommendations on adjunctive tapering of insulin in patients with insulin-dependent diabetes mellitus, which we term de-insulinization. Recent Findings GLP1-RA and SGLT2-i are the principal classes of diabetes medications evidencing cardiovascular benefit